Cramer on Biotech

In New York magazine, Jim Cramer looks at four biotech stocks; Genentech, Celgene, Gilead and Genzyme. I’d also throw in Amgen. I really wish JJC would do more articles like this. He’s good at it, and I think he’s right.

Posted by on March 5th, 2007 at 7:51 am


The information in this blog post represents my own opinions and does not contain a recommendation for any particular security or investment. I or my affiliates may hold positions or other interests in securities mentioned in the Blog, please see my Disclaimer page for my full disclaimer.